1
|
Shen L and Turner JR: Role of epithelial
cells in initiation and propagation of intestinal inflammation.
Eliminating the static: Tight junction dynamics exposed. Am J
Physiol Gastrointest Liver Physiol. 290:G577–G582. 2006. View Article : Google Scholar : PubMed/NCBI
|
2
|
Turner JR: Intestinal mucosal barrier
function in health and disease. Nat Rev Immunol. 9:799–809. 2009.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Martínez C, Lobo B, Pigrau M, Ramos L,
González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I,
Azpiroz F, et al: Diarrhoea-predominant irritable bowel syndrome:
An organic disorder with structural abnormalities in the jejunal
epithelial barrier. Gut. 62:1160–1168. 2013. View Article : Google Scholar
|
4
|
Keszthelyi D, Troost FJ, Jonkers DM, van
Eijk HM, Lindsey PJ, Dekker J, Buurman WA and Masclee AA:
Serotonergic reinforcement of intestinal barrier function is
impaired in irritable bowel syndrome. Aliment Pharmacol Ther.
40:392–402. 2014. View Article : Google Scholar : PubMed/NCBI
|
5
|
Cheng P, Yao J, Wang C, Zhang L and Kong
W: Molecular and cellular mechanisms of tight junction dysfunction
in the irritable bowel syndrome. Mol Med Rep. 12:3257–3264.
2015.PubMed/NCBI
|
6
|
Barbara G: Mucosal barrier defects in
irritable bowel syndrome. Who left the door open? Am J
Gastroenterol. 101:1295–1298. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Camilleri M and Gorman H: Intestinal
permeability and irri table bowel syndrome. Neurogastroenterol
Motil. 19:545–552. 2007. View Article : Google Scholar : PubMed/NCBI
|
8
|
Dunlop SP, Hebden J, Campbell E, Naesdal
J, Olbe L, Perkins AC and Spiller RC: Abnormal intestinal
permeability in subgroups of diarrhea-predominant irritable bowel
syndromes. Am J Gastroenterol. 101:1288–1294. 2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Piche T, Barbara G, Aubert P, Bruley des
Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De
Giorgio R, Galmiche JP, et al: Impaired intestinal barrier
integrity in the colon of patients with irritable bowel syndrome:
Involvement of soluble mediators. Gut. 58:196–201. 2009. View Article : Google Scholar
|
10
|
Thabane M and Marshall JK: Post-infectious
irritable bowel syndrome. World J Gastroenterol. 15:3591–3596.
2009. View Article : Google Scholar : PubMed/NCBI
|
11
|
Spiller RC, Jenkins D, Thornley JP, Hebden
JM, Wright T, Skinner M and Neal KR: Increased rectal mucosal
enteroendocrine cells, T lymphocytes, and increased gut
permeability following acute Campylobacter enteritis and in
post-dysenteric irritable bowel syndrome. Gut. 47:804–811. 2000.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Guilarte M, Santos J, de Torres I, Alonso
C, Vicario M, Ramos L, Martínez C, Casellas F, Saperas E and
Malagelada JR: Diarrhoea-predominant IBS patients show mast cell
activation and hyperplasia in the jejunum. Gut. 56:203–209. 2007.
View Article : Google Scholar
|
13
|
Walker MM, Talley NJ, Prabhakar M,
Pennaneac'h CJ, Aro P, Ronkainen J, Storskrubb T, Harmsen WS,
Zinsmeister AR and Agreus L: Duodenal mastocytosis, eosinophilia
and intraepithelial lymphocytosis as possible disease markers in
the irritable bowel syndrome and functional dyspepsia. Aliment
Pharmacol Ther. 29:765–773. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Ohman L and Simrén M: Pathogenesis of IBS:
Role of inflammation, immunity and neuroimmune interactions. Nat
Rev Gastroenterol Hepatol. 7:163–173. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Sundin J, Rangel I, Kumawat AK,
Hultgren-Hörnquist E and Brummer RJ: Aberrant mucosal lymphocyte
number and subsets in the colon of post-infectious irritable bowel
syndrome patients. Scand J Gastroenterol. 49:1068–1075. 2014.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Bhuiyan MR, Majumder TK, Raihan AA, Roy
PK, Farha N and Kamal M: Histopathological alterations in
post-infectious irritable bowel syndrome in Bangladeshi population.
Mymensingh Med J. 19:275–281. 2010.PubMed/NCBI
|
17
|
Kirsch R and Riddell RH: Histopathological
alterations in irritable bowel syndrome. Mod Pathol. 19:1638–1645.
2006. View Article : Google Scholar : PubMed/NCBI
|
18
|
Gwee KA, Collins SM, Read NW, Rajnakova A,
Deng Y, Graham JC, McKendrick MW and Moochhala SM: Increased rectal
mucosal expression of interleukin 1beta in recently acquired
post-infectious irritable bowel syndrome. Gut. 52:523–526. 2003.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Chen J, Zhang Y and Deng Z: Imbalanced
shift of cytokine expression between T helper 1 and T helper 2
(Th1/Th2) in intestinal mucosa of patients with post-infectious
irritable bowel syndrome. BMC Gastroenterol. 12:912012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Feng B, La JH, Schwartz ES and Gebhart GF:
Irritable bowel syndrome: Methods, mechanisms, and pathophysiology.
Neural and neuro-immune mechanisms of visceral hypersensitivity in
irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol.
302:G1085–G1098. 2012. View Article : Google Scholar : PubMed/NCBI
|
21
|
Scott CL, Henri S and Guilliams M:
Mononuclear phagocytes of the intestine, the skin, and the lung.
Immunol Rev. 262:9–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Huang H, Liu JQ, Yu Y, Mo LH, Ge RT, Zhang
HP, Liu ZG, Zheng PY and Yang PC: Regulation of TWIK-related
potassium channel-1 (Trek1) restitutes intestinal epithelial
barrier function. Cell Mol Immunol. 13:110–118. 2016. View Article : Google Scholar :
|
23
|
Arnold IC, Mathisen S, Schulthess J, Danne
C, Hegazy AN and Powrie F: CD11c(+) monocyte/macrophages promote
chronic Helicobacter hepaticus-induced intestinal inflammation
through the production of IL-23. Mucosal Immunol. 9:352–363. 2016.
View Article : Google Scholar
|
24
|
Aychek T, Mildner A, Yona S, Kim KW, Lampl
N, Reich-Zeliger S, Boon L, Yogev N, Waisman A, Cua DJ, et al:
IL-23-mediated mononuclear phagocyte crosstalk protects mice from
Citrobacter rodentium-induced colon immunopathology. Nat Commun.
6:65252015. View Article : Google Scholar : PubMed/NCBI
|
25
|
Hart AL, Al-Hassi HO, Rigby RJ, Bell SJ,
Emmanuel AV, Knight SC, Kamm MA and Stagg AJ: Characteristics of
intestinal dendritic cells in inflammatory bowel diseases.
Gastroenterology. 129:50–65. 2005. View Article : Google Scholar : PubMed/NCBI
|
26
|
Silva MA, López CB, Riverin F, Oligny L,
Menezes J and Seidman EG: Characterization and distribution of
colonic dendritic cells in Crohn's disease. Inflamm Bowel Dis.
10:504–512. 2004. View Article : Google Scholar : PubMed/NCBI
|
27
|
Krajina T, Leithäuser F, Möller P,
Trobonjaca Z and Reimann J: Colonic lamina propria dendritic cells
in mice with CD4+ T cell-induced colitis. Eur J Immunol.
33:1073–1083. 2003. View Article : Google Scholar : PubMed/NCBI
|
28
|
Karlis J, Penttila I, Tran TB, Jones B,
Nobbs S, Zola H and Flesch IE: Characterization of colonic and
mesenteric lymph node dendritic cell subpopulations in a murine
adoptive transfer model of inflammatory bowel disease. Inflamm
Bowel Dis. 10:834–847. 2004. View Article : Google Scholar
|
29
|
Long Y, Wang W, Wang H, Hao L, Qian W and
Hou X: Characteristics of intestinal lamina propria dendritic cells
in a mouse model of postinfectious irritable bowel syndrome. J
Gastroenterol Hepatol. 27:935–944. 2012. View Article : Google Scholar
|
30
|
Li M, Zhang L, Lu B, Chen Z, Chu L, Meng L
and Fan Y: Role of dendritic cell-mediated abnormal immune response
in visceral hypersensitivity. Int J Clin Exp Med. 8:13243–13250.
2015.PubMed/NCBI
|
31
|
Jones RC III, Otsuka E, Wagstrom E, Jensen
CS, Price MP and Gebhart GF: Short-term sensitization of colon
mechanoreceptors is associated with long-term hypersensitivity to
colon distention in the mouse. Gastroenterology. 133:184–194. 2007.
View Article : Google Scholar : PubMed/NCBI
|
32
|
Al-Chaer ED, Kawasaki M and Pasricha PJ: A
new model of chronic visceral hypersensitivity in adult rats
induced by colon irritation during postnatal development.
Gastroenterology. 119:1276–1285. 2000. View Article : Google Scholar : PubMed/NCBI
|
33
|
Velin AK, Ericson AC, Braaf Y, Wallon C
and Söderholm JD: Increased antigen and bacterial uptake in
follicle associated epithelium induced by chronic psychological
stress in rats. Gut. 53:494–500. 2004. View Article : Google Scholar : PubMed/NCBI
|
34
|
Keita AV, Söderholm JD and Ericson AC:
Stress-induced barrier disruption of rat follicle-associated
epithelium involves corticotropin-releasing hormone, acetylcholine,
substance P, and mast cells. Neurogastroenterol Motil. 22:770–778.
2010. View Article : Google Scholar : PubMed/NCBI
|
35
|
Overman EL, Rivier JE and Moeser AJ: CRF
induces intestinal epithelial barrier injury via the release of
mast cell proteases and TNF-α. PLoS One. 7:e399352012. View Article : Google Scholar
|
36
|
Pozzo Miller LD and Landis DM: Cytoplasmic
structure in organotypic cultures of rat hippocampus prepared by
rapid freezing and freeze-substitution fixation. Synapse.
13:195–205. 1993. View Article : Google Scholar : PubMed/NCBI
|
37
|
Siddiqui KR, Laffont S and Powrie F:
E-cadherin marks a subset of inflammatory dendritic cells that
promote T cell-mediated colitis. Immunity. 32:557–567. 2010.
View Article : Google Scholar : PubMed/NCBI
|
38
|
McDole JR, Wheeler LW, McDonald KG, Wang
B, Konjufca V, Knoop KA, Newberry RD and Miller MJ: Goblet cells
deliver luminal antigen to CD103+ dendritic cells in the
small intestine. Nature. 483:345–349. 2012. View Article : Google Scholar : PubMed/NCBI
|
39
|
Cascio JA, Haymaker CL, Divekar RD,
Zaghouani S, Khairallah MT, Wan X, Rowland LM, Dhakal M, Chen W and
Zaghouani H: Antigen-specific effector CD4 T lymphocytes school
lamina propria dendritic cells to transfer innate tolerance. J
Immunol. 190:6004–6014. 2013. View Article : Google Scholar : PubMed/NCBI
|
40
|
Poritz LS, Garver KI, Tilberg AF and
Koltun WA: Tumor necrosis factor alpha disrupts tight junction
assembly. J Surg Res. 116:14–18. 2004. View Article : Google Scholar : PubMed/NCBI
|
41
|
McDermott JR, Bartram RE, Knight PA,
Miller HR, Garrod DR and Grencis RK: Mast cells disrupt epithelial
barrier function during enteric nematode infection. Proc Natl Acad
Sci USA. 100:7761–7766. 2003. View Article : Google Scholar : PubMed/NCBI
|
42
|
Edelblum KL and Turner JR: The tight
junction in inflammatory disease: Communication breakdown. Curr
Opin Pharmacol. 9:715–720. 2009. View Article : Google Scholar : PubMed/NCBI
|
43
|
Al-Sadi R, Ye D, Boivin M, Guo S, Hashimi
M, Ereifej L and Ma TY: Interleukin-6 modulation of intestinal
epithelial tight junction permeability is mediated by JNK pathway
activation of claudin-2 gene. PLoS One. 9:e853452014. View Article : Google Scholar : PubMed/NCBI
|
44
|
Al-Sadi R, Boivin M and Ma T: Mechanism of
cytokine modulation of epithelial tight junction barrier. Front
Biosci (Landmark Ed). 14:2765–2778. 2009. View Article : Google Scholar
|
45
|
Bercík P, Wang L, Verdú EF, Mao YK,
Blennerhassett P, Khan WI, Kean I, Tougas G and Collins SM:
Visceral hyperalgesia and intestinal dysmotility in a mouse model
of postinfective gut dysfunction. Gastroenterology. 127:179–187.
2004. View Article : Google Scholar : PubMed/NCBI
|
46
|
Fu Y, Wang W, Tong J, Pan Q, Long Y, Qian
W and Hou X: Th17 cells influence intestinal muscle contraction
during Trichinella spiralis infection. J Huazhong Univ Sci
Technolog Med Sci. 29:481–485. 2009. View Article : Google Scholar : PubMed/NCBI
|